MRC IAA 2021 University of Sunderland
Lead Research Organisation:
University of Sunderland
Department Name: Sch of Pharmacy & Pharmaceutical Sci
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Technical Summary
The MRC Impact Acceleration Accounts is a key part of MRC's translational research strategy and provides annual awards to institutions to flexibly support a portfolio of translational research projects. MRC IAA is designed to accelerate the transition from discovery research to viable translational projects by supporting preliminary studies to establish proof-of-concept and to rapidly de-risk projects across the whole translational pathway so that they become competitive for substantial funding for development.
People |
ORCID iD |
| Adrian Moore (Principal Investigator) |
Publications
Kietsiriroje N
(2024)
Plasma levels of mannan-binding lectin-associated serine proteases are increased in type 1 diabetes patients with insulin resistance.
in Clinical and experimental immunology
| Description | Novel multi-antigen array for cardiovascular risk detection in type 1 diabetes |
| Organisation | Technical University of Denmark |
| Country | Denmark |
| Sector | Academic/University |
| PI Contribution | Partnership between the University of Sunderland, University of Leeds and the Technical University of Denmark (TUD). TUD will manufacture the novel multi-antigen array and validate findings with an alternative technique. Leeds and Sunderland will provide the clinical cohort, and statistical analysis will be performed by Sunderland. |
| Collaborator Contribution | Partnership between the University of Sunderland, University of Leeds and the Technical University of Denmark (TUD). TUD will manufacture the novel multi-antigen array and validate findings with an alternative technique. Leeds and Sunderland will provide the clinical cohort, and statistical analysis will be performed by Sunderland. |
| Impact | N/A |
| Start Year | 2023 |
| Description | Novel multi-antigen array for cardiovascular risk detection in type 1 diabetes |
| Organisation | University of Leeds |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Partnership between the University of Sunderland, University of Leeds and the Technical University of Denmark (TUD). TUD will manufacture the novel multi-antigen array and validate findings with an alternative technique. Leeds and Sunderland will provide the clinical cohort, and statistical analysis will be performed by Sunderland. |
| Collaborator Contribution | Partnership between the University of Sunderland, University of Leeds and the Technical University of Denmark (TUD). TUD will manufacture the novel multi-antigen array and validate findings with an alternative technique. Leeds and Sunderland will provide the clinical cohort, and statistical analysis will be performed by Sunderland. |
| Impact | N/A |
| Start Year | 2023 |
| Description | Quality control in salivary biomarker collection for oral and general wellbeing |
| Organisation | Newcastle University |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | The University of Sunderland will provide the expertise for saliva collection and perform all collection and testing assays. Newcastle University will provide clinical expertise and background IP relating to two biomarkers. Salvivo will provide advice relating to commercialisation. |
| Collaborator Contribution | The University of Sunderland will provide the expertise for saliva collection and perform all collection and testing assays. Newcastle University will provide clinical expertise and background IP relating to two biomarkers. Salvivo will provide advice relating to commercialisation. |
| Impact | N/A |
| Start Year | 2022 |
| Description | Rapid identification of S. aureus derived sepsis using Two-photon microscopy |
| Organisation | Femtonics |
| Country | Hungary |
| Sector | Private |
| PI Contribution | The University of Sunderland will provide medicinal chemistry expertise and perform all probe synthesis and microbiology testing assays. Femtonics will provide the expertise and equipment to perform two-photon microscopy. NUTH will provide clinical expertise. |
| Collaborator Contribution | The University of Sunderland will provide medicinal chemistry expertise and perform all probe synthesis and microbiology testing assays. Femtonics will provide the expertise and equipment to perform two-photon microscopy. NUTH will provide clinical expertise. |
| Impact | N/A |
| Start Year | 2018 |
| Description | Rapid identification of S. aureus derived sepsis using Two-photon microscopy |
| Organisation | Newcastle upon Tyne Hospitals NHS Foundation Trust |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | The University of Sunderland will provide medicinal chemistry expertise and perform all probe synthesis and microbiology testing assays. Femtonics will provide the expertise and equipment to perform two-photon microscopy. NUTH will provide clinical expertise. |
| Collaborator Contribution | The University of Sunderland will provide medicinal chemistry expertise and perform all probe synthesis and microbiology testing assays. Femtonics will provide the expertise and equipment to perform two-photon microscopy. NUTH will provide clinical expertise. |
| Impact | N/A |
| Start Year | 2018 |